Question: Last Call For Abstracts: High Throughput Sequencing Methods And Applications
0
ratschg@mskcc.org • 10 wrote:
Dear NGS users/developers,
please consider sending your work on NGS methods and applications to
the 5th Hitseq meeting. This year it is going to be in Long Beach, CA.
Please find the (last) call for abstracts below.
Cheers, Gunnar
HiTSeq 2012: Conference on High Throughput Sequencing Methods and
Applications
http://www.hitseq.org
July 13-14, 2012 in Long Beach, CA, USA
Last Call for Abstracts (Deadline Extended)
Key Dates:
* June 1st Abstract submission deadline (EXTENDED)
* June 8th Oral/Poster Presentation Decisions
* June 30th Late breaking poster deadline
* July 13-14 - Conference
Overview:
The Conference on High Throughput Sequencing Methods and Applications
(HiTSeq 2012) is a Satellite of the ISMB 2012 conference and brings
together biologists and computational scientists interested in
exploring the challenges and opportunities in the analysis of high-
throughput sequencing (HTS) technologies. HiTSeq 2012 welcomes
submissions on any topic related to high throughput sequencing
technologies. We are especially interested in presentations describing
methodology to infer various genetic variants (SNVs, small and larger
insertions/deletions, copy number variants), methods for analysis of
RNA sequencing data (RNA expression, de-novo transcriptome sequencing,
novel transcript discovery), and other applications of HTS
(transcription factor binding site discovery, methylation profiling,
cancer somatic aberration analysis, genome-wide disease association
studies by HTS, metagenomics). We are also interested in algorithms
for compressing and handling effectively large amounts of HTS data,
and the analysis of data from the emerging 3rd and 4th generation
sequencing platforms.
Keynotes:
* Dr. Chris Sander. Chair, Computational Biology Program, Memorial
Sloan Kettering Cancer Center.
* Dr. Stan Nelson. UCLA Jonsson Comprehensive Cancer Center.
New: Special track on Personal Genomes for Individualized Medicine
There is currently a surge in the sequencing of personal genomes
(or
exomes) with the intent of applying them in clinical decision-making.
identification of somatic mutations in cancer tumors to guide therapy
selection, to the prediction of susceptibility to complex disease to
enable prophylactic actions, the applications of personal genomes
herald an imminent change in how clinicians use genetic information in
individualized medicine. Nevertheless, an analysis bottleneck is
becoming apparent, and thus algorithms, methods, visualizations, and
efficient software to handle the onslaught of medical genomic
information are badly needed.
In this special track of HiTSeq 2012 we aim to showcase the methods
and tools that academic and industry researchers are developing in
this area, and to encourage a vigorous discussion of what is needed to
go forward. We are seeking paper and abstract submissions with an
emphasis on analysis methods for the case when the sample size is n=1
(i.e. the patient), how to make genome sequence analysis efficient &
clinical grade, as well as new techniques to summarize the wealth of
genomic information for clinical decision-making. Applications ranging
childhood diseases, cancer treatment, and complex disease
susceptibility are all welcome. This special track session will be
held on the second day of the SIG (July 14).
Abstracts:
Simultaneously, HiTSeq also allows for submission of abstracts, which
will be evaluated independently for the meeting proceedings. The
abstracts should target topics of immediate relevance in the field. To
be considered for an oral presentation the material should not have
been previously published in any journal or proceedings. Late breaking
poster abstracts will be also accepted for exceptional research
results that became available after the other deadlines. Please check
the conference website for submission instructions.
Oral/Poster presentations:
Presentations at HiTSeq may be either plenary talks or a poster at the
meetings poster session. The final decisions whether each paper or
abstract is presented as a talk or a poster will be made by May 30.
Organizers:
Gunnar Rätsch, Sloan-Kettering Institute, USA
Francisco M. De La Vega, Stanford University, USA
Inanc Birol, British Columbia Cancer Agency, Canada
Sohrab Shah, British Columbia Cancer Agency, Canada
Questions? Contact e-mail: hitseq2012@hitseq.org
--
Dr. Gunnar Rätsch
Associate Professor and Lab Head
Computational Biology Center
Memorial Sloan-Kettering Cancer Center
Office address:
415-417 E 68th street, Room Z-690
New York, NY 10065, USA
Postal address:
1275 York Avenue, Box 357
New York, NY 10065, USA
http://ratschlab.org
ratschg@mskcc.org
p: +1 646 888 2802
f: +1 646 888 3105
=====================================================================
Please note that this e-mail and any files transmitted from
Memorial Sloan-Kettering Cancer Center may be privileged,
confidential,
and protected from disclosure under applicable law. If the reader
of
this message is not the intended recipient, or an employee or
agent
responsible for delivering this message to the intended
recipient,
you are hereby notified that any reading, dissemination,
distribution,
copying, or other use of this communication or any of its
attachments
is strictly prohibited. If you have received this communication
in
error, please notify the sender immediately by replying to this
message
and deleting this message, any attachments, and all copies and
backups
from your computer.